The inducing effect of agonist anti-CD40 mAb 5C11 on leukemic dendritic cells

被引：0
|
作者：
Wang, Z [1 ]
Gu, Y [1 ]
Zhang, X [1 ]
机构：
[1] Soochow Univ, Inst Biotechnol, Suzhou, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
471
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [21] Timing of melanoma brain metastasis seeding dictates the immunomodulatory effect and efficacy of systemic anti-CD40 agonist therapy
    Cheng, Vinton W. T.
    Breza, Victoria R.
    Chertok, Beata
    Sheybani, Natasha D.
    Bullock, Timothy N. J.
    Price, Richard J.
    CANCER RESEARCH, 2024, 84 (22)
  • [22] Immunosuppression by a novel Anti-CD40 mAb, 4D11, is not arogated by combined treatment with tacrolimus for renal transplantation in cynomolgus monkeys.
    Uno, Motohiro
    Suzuki, Tomomi
    Aoyagi, Takeshi
    Sugitani, Atsushi
    Goto, Ryoichi
    Yamashita, Kenichiro
    Miura, Toru
    Takahashi, Nobuaki
    Itoh, Tomoo
    Taniguchi, Masahiko
    Shimamura, Tsuyoshi
    Furukawa, Hiroyuki
    Todo, Satoru
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 202 - 202
  • [23] Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effect of an anti-CD40 immunotoxin
    Francisco, JA
    Kiener, PA
    MoranDavis, P
    Ledbetter, JA
    Siegall, CB
    JOURNAL OF IMMUNOLOGY, 1996, 157 (04): : 1652 - 1658
  • [24] Selective effect of burn injury on splenic CD11c+ dendritic cells and CD8α+CD4-CD11c+ dendritic cell subsets
    Patenaude, Julie
    D'Elia, Michele
    Hamelin, Claudine
    Bernier, Jacques
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (08) : 1315 - 1329
  • [25] Selective effect of burn injury on splenic CD11c+ dendritic cells and CD8α+CD4−CD11c+ dendritic cell subsets
    Julie Patenaude
    Michele D’Elia
    Claudine Hamelin
    Jacques Bernier
    Cellular and Molecular Life Sciences, 2010, 67 : 1315 - 1329
  • [26] Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells
    Honeychurch, J
    Glennie, LJ
    Illidge, TM
    CANCER RESEARCH, 2005, 65 (16) : 7493 - 7501
  • [27] Cyclophosphamide induced CD11B+ cells can inhibit anti-CD40 monoclonal antibody therapy of B-cell lymphoma
    Honeychurch, J
    Glennie, MJ
    Illidge, TM
    BRITISH JOURNAL OF CANCER, 2004, 91 : S64 - S64
  • [28] RETRACTION: Combined therapy using LHRH-PE40 and anti-CD40 dendritic cells substantially eliminate tumor cells (Retraction of Vol 120, Pg 8093, 2019)
    Zhang, Limin
    Du, TianJiao
    Ma, DongBin
    Guo, Fang
    Li, ZhenWei
    Yan, Hua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) : 495 - 495
  • [29] Immunological aspects of non-human primates renal transplant recipients treated with a novel human anti-CD40 MAB, 4D11 and tacrolimus.
    Uno, Motobiro
    Yamashita, Kenichiro
    Suzuki, Tomomi
    Aoyagi, Takeshi
    Goto, Ryoichi
    Oura, Tetu
    Watanabe, Masaaki
    Miura, Toru
    Takahashi, Nobuaki
    Okimura, Kazumitsu
    Itoh, Tomoo
    Shimizu, Akira
    Taniguchi, Masahiko
    Shimamura, Tsuyoshi
    Furukawa, Hiroyuki
    Todo, Satoru
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 228 - 228
  • [30] CD11c+ Dendritic Cells and B Cells Contribute to the Tumoricidal Activity of Anti-DR5 Antibody Therapy in Established Tumors
    Haynes, Nicole M.
    Hawkins, Edwin D.
    Li, Ming
    McLaughlin, Nicole M.
    Haemmerling, Guenther J.
    Schwendener, Reto
    Winoto, Astar
    Wensky, Allen
    Yagita, Hideo
    Takeda, Kazuyoshi
    Kershaw, Michael H.
    Darcy, Phillip K.
    Smyth, Mark J.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (01): : 532 - 541
12345